"Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain".


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 29 08 2022
revised: 22 12 2022
accepted: 31 01 2023
medline: 3 4 2023
pubmed: 2 3 2023
entrez: 1 3 2023
Statut: ppublish

Résumé

Celiac disease is strongly associated with HLA DQ, specifically with haplotypes. DRB1*03-DQA1*05:01/DQB1*02:01 (DQ2.5),DRB1*07-DQA1*02:01/DQB1*02:02 (DQ2.2), DRB1*11-DQA1*05:05/DQB1*03:01 (DQ7.5), and DRB1*04-DQA1*03:01/DQB1*03:02 (DQ8). The distribution of these risk haplotypes in patients with celiac disease is different in the geographical areas investigated. A high frequency of DRB1*07- DQA1*02:01/DQB1*02:02 (DQ2.2) and DRB1*11-DQA1*05:05/DQB1*03:01 (DQ7.5), has been described in Southern Europe. We analyzed 2102 confirmed CD cases with information on both DQB1* alelles and their distribution by geographical area in Spain. According to the presence of this haplotype in one or two chromosomes, the genotype is classified in: DQ2 homozygous, DQ2 heterozygous (cis or trans), DQ8 homozygous, DQ8/DQ2.5, DQ 2.2 homozygous and genotype known as "half DQ2". Two different patterns of risks related to CD were identified. In the Basque Country and Navarre, the Mediterranean Area (Aragon, Catalonia, Valencia, Balearic Islands, and Murcia), the South of Spain (Andalucía and Extremadura), and the Canary Islands, higher frequency of DQ2.5 trans, and more than 80% of DQ2.5/DQ2.2 homozygosis were described. The Cantabrian Coast (Cantabria, Asturias, and Galicia) and Central Areas (Castilla-León and Castilla-La Mancha) showed a higher percentage of DQ2.5/DQ2.5 homozygosis and a lower DQ2.5 in trans frequency, as in Northern Europe. Madrid has an intermediate model between the two described above. 17 cases (0.8%) did not carry any CD risk haplotypes.

Identifiants

pubmed: 36858916
pii: S0198-8859(23)00025-3
doi: 10.1016/j.humimm.2023.01.010
pii:
doi:

Substances chimiques

HLA-DQ Antigens 0
HLA-DQ beta-Chains 0
HLA-DQ alpha-Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

290-295

Investigateurs

Margarita Pich (M)
Ana Arévalo (A)
Sonia Fernández (S)
David Gil (D)
Pablo Oliver (P)
Juan Manuel Bartolomé (J)
José Vicente Arcos (J)
Francisco Pérez (F)
Haydeé Expósito (H)
Juana M Rizo (JM)
Víctor Manuel Navas (V)
Rafael González de Caldas (R)
María Jesús Balboa (M)
Cristina Molinos (C)
Laura Alonso (L)
Helena Lorenzo (H)
José Bernardo González (J)
María Lluïsa Masiques (M)
Ana Isabel Ruiz (A)
José Ignacio Olazábal (J)

Informations de copyright

Copyright © 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Félix Sánchez-Valverde (F)

Department of Paediatrics. Navarre Children's Nutrition and Digestive Study Group (GENDINA), NAVARRA BIOMED, University Hospital of Navarra, Pamplona, Spain.

Eva Martínez-Ojinaga (E)

Pediatric Gastroenterology and Nutrition Department, University Hospital La Paz, Madrid, Spain.

Ester Donat (E)

Pediatric Gastroenterology and Hepatology Unit, Hospital Universitari i Politècnic La Fe and celiac disease and digestive immunopathology unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Andrés Bodas (A)

Hospital Clnico San Carlos, Madrid, Spain.

Eva Bandrés (E)

Inmunology Unit, Hematology Service, University Hospital of Navarra, IDISNA Pamplona. Spain.

Ricardo Torres (R)

Hospital Universitario de Salamanca, Salamanca, Spain.

Berta Ibáñez (B)

Navarrabiomed-CHN-UPNA, REDISSEC, RICAPPS, IdiSNA, Pamplona, Spain.

Mª Luz Cilleruelo (ML)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Gemma Castillejo (G)

Pediatric Gastroenterology, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgil, IISPV, Reus. Spain.

David Pérez-Solis (D)

Hospital Universitario San Agustín, Avilés, Spain.

Carlos Ochoa (C)

Hospital Virgen de la Concha. Zamora, Spain.

Francisco Javier Eizaguirre (FJ)

Hospital Universitario Donostia. Donostia, Spain.

Salvador García (S)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Jose Ignacio García (JI)

Complejo Hospitalario Universitario de Vigo, Vigo, Spain.

Josefa Barrio (J)

Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.

Raquel Vecino (R)

Hospital Clnico San Carlos, Madrid, Spain.

María Del Carmen Miranda (MDC)

Hospital Universitario Infanta Cristina, Parla, Spain.

Mercedes Juste (M)

Hospital Universitario San Juan de Alicante, Alicante, Spain.

Jose Carlos Salazar (JC)

Hospital Universitario Infantil Virgen del Rocío, Sevilla, Spain.

Honorio Armas (H)

Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.

Luis Ortigosa (L)

Hospital Universitario Virgen de la Candelaria, Santa Cruz de Tenerife, Spain.

Pedro Urruzuno (P)

Hospital Universitario Doce de Octubre, Madrid, Spain.

Zuriñe García (Z)

Hospital Universitario de Araba - Txagorritxu, Vitoria, Spain.

Elena Balmaseda (E)

Complejo Universitario de Albacete, Albacete, Spain.

Cecilia Martinez-Costa (C)

Hospital Clínico Universitario de Valencia, Valencia, Spain.

Enrique La Orden (E)

Hospital Universitario Infanta Elena, Valdemoro, Spain.

Pilar Codoñer (P)

Hospital Universitario Dr. Peset, Valencia, Spain.

Amadeu Roca (A)

Hospital Comarcal Sant Jaume de Calella, Calella, Spain.

Carlos Trillo (C)

Hospital de La Axarquía, Vélez, Spain.

Mercedes Sebastian (M)

Hospital Universitario de Móstoles, Móstoles, Spain.

Ruth García (R)

Hospital Materno Infantil Miguel Servet, Zaragoza, Spain.

Luis Peña-Quintana (L)

Unidad de Gastroenterología y Nutrición Pediátrica, Complejo Hospitalario Universitario Insular Materno-Infantil, ACIP, CIBEROBN ISCIII, Universidad de Las Palmas de Gran Canaria, Spain.

Patricia Barros (P)

Complejo Hospitalario Universitario de Caceres, Spain.

Marta Soria (M)

Hospital HM Monteprincipe/Torrelodones, Torrelodones, Spain.

Roger García (R)

Hospital Mutua de Terrassa, Terrassa, Spain.

Begoña Pérez-Moneo (B)

Hospital Infanta Leonor, Madrid, Spain.

Isabel Polanco (I)

Pediatric Gastroenterology and Nutrition Department, University Hospital La Paz, Madrid, Spain.

Carmen Ribes (C)

Pediatric Gastroenterology and Hepatology Unit, Hospital Universitari i Politècnic La Fe and celiac disease and digestive immunopathology unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Enriqueta Román (E)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH